RC对2型糖尿病心血管疾病预测价值的研究进展
Research Progress on the Predictive Value of Remnant Cholesterol for Cardiovascular Disease in Type 2 Diabetes Mellitus
DOI: 10.12677/ACM.2023.1381921, PDF,   
作者: 周 婕：西安医学院研究生院，陕西 西安；郭 伟*：陕西省人民医院全科医学科，陕西 西安
关键词: 残余胆固醇；脂质代谢；2型糖尿病大血管病变；Remnant Cholesterol； Lipid Metabolism； Macroangiopathy in Type 2 Diabetes Mellitus
摘要: 近些年来，残余胆固醇(remnant cholesterol, RC)作为区别于血脂四项的预测指标被提出，并在临床验证中得到了证实。而2型糖尿病由于糖脂稳态失衡，胰岛素抵抗等原因导致动脉粥样硬化从而引发心血管疾病，欧美等国家已经开始高度重视残余胆固醇的调控，以改善心血管疾病患者预后，因此RC可以作为有效监测指标，具有一定的预测研究价值。
Abstract: In recent years, residual cholesterol (remnant cholesterol, RC) has been proposed as a predictive indicator different from the four blood lipids, and has been confirmed in clinical trials. Type 2 dia-betes mellitus is caused by atherosclerosis due to the imbalance of glucose and lipid homeostasis, insulin resistance and other reasons, which leads to cardiovascular diseases. Countries such as Eu-rope and the United States have begun to attach great importance to the regulation of residual cho-lesterol in order to improve the prognosis of patients with cardiovascular diseases. Therefore, RC can be used as an effective monitoring indicator and has certain predictive research value.
文章引用：周婕, 郭伟. RC对2型糖尿病心血管疾病预测价值的研究进展[J]. 临床医学进展, 2023, 13(8): 13750-13756. https://doi.org/10.12677/ACM.2023.1381921

参考文献

[1] Yang, W.Y., Lu, J.M., Weng, J.P., et al. (2010) Prevalence of Diabetes among Men and Women in China. The New England Journal of Medicine, 362, 1090-1101. [Google Scholar] [CrossRef] 
[2] De Rosa, S., Arci-diacono, B., Chiefari, E., et al. (2018) Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links. Frontiers in Endocrinology (Lausanne), 9, 2. [Google Scholar] [CrossRef] [PubMed]
[3] American Di-abetes Association (2021) 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care, 44, S15-S33. [Google Scholar] [CrossRef] 
[4] Bragg, F., Li, L.M., Yang, L., et al. (2016) Risks and Population Burden of Cardiovascular Diseases Associated with Diabetes in China: A Prospective Study of 0.5 Million Adults. PLOS Medicine, 13, e1002026. [Google Scholar] [CrossRef] [PubMed]
[5] Adeva-Andany, M.M., Martínez-Rodríguez, J., Gonzá-lez-Lucán, M., et al. (2019) Insulin Resistance Is a Cardiovascular Risk Factor in Humans. Diabetology Metabolic Syn-drome, 13, 1449-1455. [Google Scholar] [CrossRef] [PubMed]
[6] Kubota, T., Kubota, N., Kumagai, H., et al. (2011) Impaired Insulin Signaling in Endothelial Cells Reduces Insulin-Induced Glucose Uptake by Skeletal Muscle. Cell Metabolism, 13, 294-307. [Google Scholar] [CrossRef] [PubMed]
[7] Martínez-Hervás, S., Vinué, Á., Núñez, L., et al. (2014) Insulin Resistance Aggravates Atherosclerosis by Reducing Vascular Smooth Muscle Cell Survival and Increasing CX3CL1/CX3CR1 Axis. Cardiovascular Research, 103, 324-336. [Google Scholar] [CrossRef] [PubMed]
[8] Poetsch, F., Henze, L.A., Estepa, M., et al. (2020) Role of SGK1 in the Osteogenic Transdifferentiation and Calcification of Vascular Smooth Muscle Cells Promoted by Hyperglycemic Condi-tions. International Journal of Molecular Sciences, 21, Article No. 7207. [Google Scholar] [CrossRef] [PubMed]
[9] Turner, R.C., Millns, H., Neil, H.A., et al. (1998) Risk Factors for Coronary Artery Disease in Non-Insulin Dependent Diabetes Mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ, 316, 823-828. [Google Scholar] [CrossRef] [PubMed]
[10] Martin, S.S., Blaha, M.J., Elshazly, M.B., et al. (2013) Frie-dewald-Estimated versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications. JACC: Journal of the American College of Cardiology, 62, 732-739. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, J., Stancakova, A., Soininen, P. et al. (2012) Lipoprotein Subclass Profiles in Individuals with Varying Degrees of Glu-cose Tolerance: A Population-Based Study of 9399 Finnish Men. Journal of Internal Medicine, 272, 562-572. [Google Scholar] [CrossRef] [PubMed]
[12] Arca, M., Pigna, G. and Favoccia, C. (2012) Mechanisms of Diabetic Dyslipidemia: Relevance for Atherogenesis. Current Vascular Pharmacology, 10, 684-686. [Google Scholar] [CrossRef] [PubMed]
[13] Martin, S.S., Blaha, M.J., Elshazly, M.B., et al. (2013) Com-parison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels from the Standard Lipid Profile. JAMA, 310, 2061-2068. [Google Scholar] [CrossRef] [PubMed]
[14] Jepsen, A.M., Langsted, A., Varbo, A., et al. (2016) Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease. Clinical Chemistry, 62, 593-604. [Google Scholar] [CrossRef] [PubMed]
[15] Kulkarni, K.R. (2006) Cholesterol Profile Measurement by Vertical Auto Profile Method. Clinics in Laboratory Medicine, 26, 787-802. [Google Scholar] [CrossRef] [PubMed]
[16] 陈林滔, 田清平, 刘梅林. 残余胆固醇预测动脉粥样硬化性心血管疾病的研究进展[J]. 心血管病学进展, 2022, 43(6): 492-494.
[17] Qin, Z., Zhou, K., Li, Y.P., et al. (2019) Rem-nant Lipoproteins Play an Important Role of In-Stent Restenosis in Type 2 Diabetes Undergoing Percutaneous Coronary Intervention: A Single-Centre Observational Cohort Study. Cardiovascular Diabetology, 18, Article No. 11. [Google Scholar] [CrossRef] [PubMed]
[18] Cao, Y.X., Zhang, H.W., Jin, J.L., et al. (2020) The Longitudinal Association of Remnant Cholesterol with Cardiovascular Outcomes in Patients with Diabetes and Prediabetes. Cardio-vascular Diabetology, 19, Article No. 104. [Google Scholar] [CrossRef] [PubMed]
[19] Liu, S.L., Wu, N.Q., Shi, H.W., et al. (2020) Fibrinogen Is As-sociated with Glucose Metabolism and Cardiovascular Outcomes in Patients with Coronary Artery Disease. Cardiovas-cular Diabetology, 19, Article No. 36. [Google Scholar] [CrossRef] [PubMed]
[20] Wadström, B.N., Wulff, A.B., Pedersen, K.M., et al. (2022) El-evated Remnant Cholesterol Increases the Risk of Peripheral Artery Disease, Myocardial Infarction, and Ischaemic Stroke: A Cohort-Based Study. European Heart Journal, 43, 3258-3269. [Google Scholar] [CrossRef] [PubMed]
[21] Mosenzon, O., Alguwaihes, A., Arenas Leon, J.L., et al. (2020) CAPTURE: A Cross-Sectional Study of the Contemporary (2019) Prevalence of Cardiovascular Disease in Adults with Type 2 Diabetes across 13 Countries. Diabetologia, 63, S1-S485.

为你推荐